Patents by Inventor Thomas Kruse
Thomas Kruse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11951284Abstract: Apparatuses and methods for transitioning to sleep mode or otherwise modified glucose target range in automated insulin delivery systems. For example, sleep mode can include a lower glucose target and/or lower and narrower glucose target range because of fewer variables that affect glucose values during sleep such as eating and exercise. Due to increased stability provided by the sleep mode target range, it is desirable to transition to the sleep mode target range as quickly as possible, while ensuring the transition is done safely and does not risk low glucose or hypoglycemia by too quickly switching to the lower and narrower target range. Systems and methods disclosed herein therefore provide various approaches for safely and quickly transitioning to sleep mode or other modified target ranges in order to improve time in range by being more aggressive to get to the lower sleep mode or other target faster without risking hypoglycemia.Type: GrantFiled: August 27, 2021Date of Patent: April 9, 2024Assignee: Tandem Diabetes Care, Inc.Inventors: Alexandra Elena Constantin, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Virginia S. Lu, Garrett Marin
-
Patent number: 11945462Abstract: Systems and methods for managing speed thresholds for a fleet of vehicles are disclosed. Input is used to provide associations between particular weather-relation conditions (such as rain) and arithmetic operations, that may be used to determine a current speed threshold as a function of a local posted speed limit at the current location of a vehicle. The current speed threshold is subsequently used to detect whether vehicles are exceeding the current speed threshold.Type: GrantFiled: December 14, 2022Date of Patent: April 2, 2024Assignee: SmartDrive Systems, Inc.Inventors: Samuel Thomas Kruse, David Wagstaff, Jason Palmer
-
Publication number: 20230331803Abstract: The invention relates to a compound comprising a GLP-1 receptor agonist and an amylin receptor agonist. The invention also relates to a pharmaceutical formulation, suitable for but not limited to oral administration, which comprises such a compound. The compound and pharmaceutical formulation comprising it may be used for the medical treatment of subjects with overweight, obesity and associated co-morbidities.Type: ApplicationFiled: December 19, 2022Publication date: October 19, 2023Inventors: Thomas Kruse, Anne Louise Bank Kodal, Johnny Madsen, Soeren Oestergaard, Wouter Frederik Johan Hogendorf, Christian Wenzel Tornoee, Lauge Schaeffer, Alice Ravn Madsen
-
Publication number: 20230331745Abstract: This invention relates to glucose-sensitive albumin-binding diboron conjugates. More particularly the invention provides novel diboron compounds, and in particular diboronate or diboroxole compounds, useful as intermediate compounds for the synthesis of diboron conjugates.Type: ApplicationFiled: June 16, 2023Publication date: October 19, 2023Inventors: Thomas Kruse, Mikael Kofod-Hansen, Martin Werner Borchsenius Muenzel, Henning Thoegersen, Per Sauerberg, Jakob Ewald Rasmussen, Carsten Behrens, Thomas Hoeg-Jensen, Vojtech Balsanek, Zuzana Drobnakova, Ladislav Droz, Miroslav Havranek, Vladislav Kotek, Milan Stengl, Ivan Snajdr, Hana Drusanova
-
Patent number: 11767332Abstract: This invention relates to glucose-sensitive albumin-binding diboron conjugates. More particularly the invention provides novel diboron compounds, and in particular diboronate or diboroxole compounds, useful as intermediate compounds for the synthesis of diboron conjugates.Type: GrantFiled: October 13, 2021Date of Patent: September 26, 2023Assignee: Novo Nordisk A/SInventors: Thomas Kruse, Mikael Kofod-Hansen, Martin Werner Borchsenius Muenzel, Henning Thoegersen, Per Sauerberg, Jakob Ewald Rasmussen, Carsten Behrens, Thomas Hoeg-Jensen, Vojtech Balsanek, Zuzana Drobnakova, Ladislav Droz, Miroslav Havranek, Vladislav Kotek, Milan Stengl, Ivan Snajdr, Hana Drusanova
-
Publication number: 20230249184Abstract: Fluidic modules configured for flowing fluid through membranes and associated methods are generally provided. In some embodiments, a fluidic module comprises two channels between which a membrane is positioned. The two channels may have geometries such that the pressure drop experienced by a fluid flowing from the first channel, through the membrane, and into the second channel is substantially independent of the location along the channel at which it flows through the membrane. In other words, the pressure drop may be substantially constant over the membrane area.Type: ApplicationFiled: April 13, 2023Publication date: August 10, 2023Applicant: Sartorius Stedim Biotech GmbHInventors: Samin Akbari, Thomas Kruse, David Pollard, Markus Kampmann
-
Publication number: 20230120803Abstract: Systems and methods for managing speed thresholds for a fleet of vehicles are disclosed. Input is used to provide associations between particular weather-relation conditions (such as rain) and arithmetic operations, that may be used to determine a current speed threshold as a function of a local posted speed limit at the current location of a vehicle. The current speed threshold is subsequently used to detect whether vehicles are exceeding the current speed threshold.Type: ApplicationFiled: December 14, 2022Publication date: April 20, 2023Inventors: Samuel Thomas Kruse, David Wagstaff, Jason Palmer
-
Patent number: 11630493Abstract: A ventilation device (1) is proposed, in particular designed to ventilate a circuit board (2), preferably in or for a computer, wherein the ventilation device (1) is designed to produce a first cooling air stream (5) from a first fan (12) and to produce a second cooling air stream (7) from a second fan (13), wherein the first cooling air stream (5) and the second cooling air stream (7) flow through on different sides of an air stream boundary plane (L), preferably parallel to the air stream boundary plane (L), through a common ventilation plane (BL) perpendicular to the air stream boundary plane (L), wherein the directions of flow from the first fan (12) and the second fan (13) are crosswise to the air stream boundary plane (L), wherein the ventilation device (1) preferably is designed to be mountable such that the air stream boundary plane (L) coincides with a central plane of the circuit board.Type: GrantFiled: October 28, 2020Date of Patent: April 18, 2023Assignee: Unify GmbH & Co. KGInventor: Thomas Kruse
-
Patent number: 11565712Abstract: Systems and methods for managing speed thresholds for a fleet of vehicles are disclosed. Input is used to provide associations between particular weather-relation conditions (such as rain) and arithmetic operations, that may be used to determine a current speed threshold as a function of a local posted speed limit at the current location of a vehicle. The current speed threshold is subsequently used to detect whether vehicles are exceeding the current speed threshold.Type: GrantFiled: April 20, 2021Date of Patent: January 31, 2023Assignee: SmartDrive Systems, Inc.Inventors: Samuel Thomas Kruse, David Wagstaff, Jason Palmer
-
Patent number: 11541122Abstract: The present invention provides glucose sensitive insulin derivatives comprising a macrocycle, a glucose mimetic and human insulin or an analogue thereof, and their pharmaceutical use. Furthermore, the invention relates to pharmaceutical compositions comprising such glucose sensitive insulin derivatives, and to the use of such compounds for the treatment or prevention of medical conditions relating to diabetes.Type: GrantFiled: September 18, 2019Date of Patent: January 3, 2023Inventors: Thomas Hoeg-Jensen, Alice Ravn Madsen, Thomas Kruse, Per Sauerberg, Anthony Murray, Andrew Michael Chapman, Anthony Peter Davis
-
Publication number: 20220266552Abstract: The invention relates to a method for repairing a damaged point of a fiber composite component which is formed from at least one fiber ply of a fiber material of a fiber composite substance and a matrix material of the fiber composite substance, in which matrix material the fiber material is embedded, wherein the method comprises the following steps: removing the damaged point from the fiber composite component and producing a repair cavity in the fiber composite component, introducing at least one reparative fiber ply of a fiber material into the repair cavity produced in the fiber composite component, and curing the matrix material, in which the fiber material of the reparative fiber ply is embedded, after introducing the reparative fiber ply into the repair cavity of the fiber composite component, wherein at least one reparative fiber ply having a ply thickness that is smaller than the ply thickness of the fiber plies of the rest of the fiber composite component is introduced into the repair cavity.Type: ApplicationFiled: August 6, 2020Publication date: August 25, 2022Inventors: Dirk Holzhüter, Jens KOSMANN, Thomas Körwien, Anton Maier, Thomas Kruse-Strack
-
Publication number: 20220184184Abstract: The present invention relates to novel insulin derivatives and their use in the treatment or prevention of medical conditions relating to diabetes. The insulin derivatives are glucose sensitive and display glucose-sensitive albumin binding. The invention also relates to novel intermediates. Finally, the invention provides a pharmaceutical composition comprising the insulin derivatives of the invention and the use of such a composition in the treatment or prevention of medical conditions relating to diabetes.Type: ApplicationFiled: March 27, 2020Publication date: June 16, 2022Inventors: Thomas Hoeg-Jensen, Carsten Behrens, Emiliano Clo, Martin Werner Borchsenius Muenzel, Per Sauerberg, Thomas Kruse, Jane Spetzler, Ulrich Sensfuss, Claudia Ulrich Hjoerringgaard, Henning Thoegersen, Vojtech Balsanek, Zuzana Drobnakova, Ladislav Droz, Miroslav Havranek, Vladislav Kotek, Milan Stengl, Ivan Snajdr, Hana Drusanova
-
Patent number: 11353314Abstract: A method for determining a distance between components has the steps of providing a first conductive section in or on the first component in a region directed toward the second component, providing a second conductive section in or on the second component in a region directed toward the first conductive section, feeding a first voltage pulse into a first connection of the first conductive section, capturing a reflection voltage pulse in response to the first voltage pulse at the first connection, determining an impedance profile along the first conductive section by evaluating the reflection voltage pulse, and determining a distance between the components along the first conductive section by calculating a corresponding local distance, associated with the determined impedance profile, between the first conductive section and the second conductive section.Type: GrantFiled: June 7, 2018Date of Patent: June 7, 2022Assignees: Airbus Defence and Space GmbH, Airbus Operations GmbHInventors: Christopher Buchmann, Alois Friedberger, Thomas Kruse, Thomas Körwien
-
Publication number: 20220081451Abstract: This invention relates to glucose-sensitive albumin-binding diboron conjugates. More particularly the invention provides novel diboron compounds, and in particular diboronate or diboroxole compounds, useful as intermediate compounds for the synthesis of diboron conjugates.Type: ApplicationFiled: October 13, 2021Publication date: March 17, 2022Inventors: Thomas Kruse, Mikael Kofod-Hansen, Martin Werner Borchsenius Muenzel, Henning Thoegersen, Per Sauerberg, Jakob Ewald Rasmussen, Carsten Behrens, Thomas Hoeg-Jensen, Vojtech Balsanek, Zuzana Drobnakova, Ladislav Droz, Miroslav Havranek, Vladislav Kotek, Milan Stengl, Ivan Snajdr, Hana Drusanova
-
Publication number: 20220047708Abstract: The present invention provides glucose sensitive insulin derivatives comprising a macrocycle, a glucose mimetic and human insulin or an analogue thereof, and their pharmaceutical use. Furthermore, the invention relates to pharmaceutical compositions comprising such glucose sensitive insulin derivatives, and to the use of such compounds for the treatment or prevention of medical conditions relating to diabetes.Type: ApplicationFiled: September 18, 2019Publication date: February 17, 2022Inventors: Thomas Hoeg-Jensen, Alice Ravn Madsen, Thomas Kruse, Per Sauerberg, Anthony Murray, Andrew Michael Chapman, Anthony Peter Davis
-
Publication number: 20220033106Abstract: An indication device for monitoring the structural integrity of a repair location on a laminate structure, produced from a composite material, of a part of an aircraft outer skin is specified. The indication device has at least one elongate, thin indicator strip. The indicator strip is detachably applied to the outer layer of the laminate structure in the immediate vicinity of the repair location. The indicator strip is designed to indicate a predefined residual strength of an adhesive joint of a repair patch to the surrounding composite material.Type: ApplicationFiled: November 25, 2019Publication date: February 3, 2022Applicant: Airbus Defence and Space GmbHInventors: Thomas Körwien, Anton Maier, Thomas Kruse, Jens Holtmannspötter
-
Patent number: 11201893Abstract: A system for assessing potential cybersecurity threats to a subject system is provided. The system includes a computer system including at least one processor in communication with at least one memory device. The at least one processor is programmed to: receive a subject system to analyze, determine a potential hazard event associated with the subject system, generate an attack graph associated with the potential hazard event, wherein the attack graph includes a plurality of actions, determine an exploitability score for each of the plurality of actions, determine an uncertainty level for each of the plurality of actions based on the corresponding exploitability score, aggregate the plurality of actions including the corresponding exploitability scores and the corresponding uncertainty levels to determine one or more vulnerabilities of the subject system, and generate a response to the one or more vulnerabilities of the subject system.Type: GrantFiled: October 8, 2019Date of Patent: December 14, 2021Assignee: THE BOEING COMPANYInventors: David Thomas Kruse, Benjamin Joseph Steffes, Nathan Mackey, Moon Kim
-
Patent number: 11186595Abstract: This invention relates to glucose-sensitive albumin-binding diboron conjugates. More particularly the invention provides novel diboron compounds, and in particular diboronate or diboroxole compounds, useful as intermediate compounds for the synthesis of diboron conjugates. The diboron compounds are characterized by formula (I), which is: R1-X—R2, and wherein “X” is a mono- to multiatomic linker and where R1 and R2, which may be identical or different, each represents a group of Formula (11a) or (IIb) Also described are diboron conjugates represented by the general Formula (I?), which is: R1?-X?—R2?, in which either the moeities R1? or R2? or X? carry a drug that is covalently attached to the diboron compound.Type: GrantFiled: November 8, 2018Date of Patent: November 30, 2021Assignee: Novo Nordisk A/SInventors: Thomas Kruse, Mikael Kofod-Hansen, Martin Werner Borchsenius Muenzel, Henning Thoegersen, Per Sauerberg, Jakob Ewald Rasmussen, Carsten Behrens, Thomas Hoeg-Jensen, Vojtech Balsanek, Zuzana Drobnakova, Ladislav Droz, Miroslav Havranek, Vladislav Kotek, Milan Stengl, Ivan Snajdr, Hana Drusanova
-
Patent number: 11117947Abstract: The invention relates to a derivative of a GLP-1 analogue, which analogue comprises a first K residue at a position corresponding to position 27 of GLP-1(7-37) (SEQ ID NO: 1); a second K residue at a position corresponding to position T of GLP-1(7-37), where T is an integer in the range of 7-37 except 18 and 27; and a maximum of ten amino acid changes as compared to GLP-1(7-37); wherein the first K residue is designated K27, and the second K residue is designated KT; which derivative comprises two albumin binding moieties attached to K27 and KT, respectively, via a linker, wherein the albumin binding moiety comprises a protracting moiety selected from HOOC—(CH2)x—CO— and HOOC—C6H4—O—(CH2)y—CO—; in which x is an integer in the range of 6-16, and y is an integer in the range of 3-17; wherein the linker comprises an element of the formula —NH—(CH2)2—(O—(CH2)2)k—O—(CH2)n—CO—, wherein k is an integer in the range of 1-5, and n is an integer in the range of 1-5; or a pharmaceutically acceptable salt, amide, or esteType: GrantFiled: November 22, 2019Date of Patent: September 14, 2021Assignee: Novo Nordisk A/SInventors: Birgit Wieczorek, Jane Spetzler, Thomas Kruse, Lars Linderoth, Jacob Kofoed
-
Publication number: 20210263184Abstract: Systems and methods for detecting a sitting duck scenario of a vehicle on or near a road are disclosed. The current location and speed of the vehicle are used for different comparisons and/or determinations, including a comparison to road-specific information to determine whether the vehicle is in a particular proximity of a highway, and a determination whether the vehicle has been stationary continuously for at least a specified duration. Additional comparisons and/or determinations may be used. If such an occurrence has been detected, one or more notifications are generated, and provided to one or more of the vehicle operator and/or a remote computing server.Type: ApplicationFiled: February 12, 2021Publication date: August 26, 2021Inventors: David Wagstaff, Samuel Thomas Kruse, Jason Palmer